国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2013年
14期
1062-1064
,共3页
赵建清%李旺%刘晓%张淑萍%钱海红
趙建清%李旺%劉曉%張淑萍%錢海紅
조건청%리왕%류효%장숙평%전해홍
肺康饮%非小细胞肺癌%肺肿瘤%生活质量%免疫学
肺康飲%非小細胞肺癌%肺腫瘤%生活質量%免疫學
폐강음%비소세포폐암%폐종류%생활질량%면역학
Fei Kang Yin%Non-small cell lung cancer%Lung neoplasms%Quality of life%Immunology
目的 观察肺康饮结合化疗改善中晚期非小细胞肺癌患者生活质量及机体免疫功能的作用.方法 将84例中晚期非小细胞肺癌患者随机分为治疗组和对照组,各42例.对照组单纯GP化疗方案,治疗组采用中药复方肺康饮口服液结合GP化疗方案.21d为1个疗程,治疗3个疗程后,观察近期疗效、中医临床症候变化、治疗前后生活质量和免疫功能的变化以及化疗不良反应.结果 治疗组近期疗效有效率为81.0%;中医临床症候改善有效率为92.9%;生活质量KPS评分与对照组比较差异有统计学意义(P<0.05);治疗组T细胞亚群水平变化与对照组比较差异有统计学意义(P<0.05);化疗不良反应基本在可控制范围内.结论 肺康饮结合化疗治疗中晚期非小细胞肺癌,可显著提高患者机体免疫功能,改善生活质量,是一种疗效肯定、安全性高的综合治疗方法.
目的 觀察肺康飲結閤化療改善中晚期非小細胞肺癌患者生活質量及機體免疫功能的作用.方法 將84例中晚期非小細胞肺癌患者隨機分為治療組和對照組,各42例.對照組單純GP化療方案,治療組採用中藥複方肺康飲口服液結閤GP化療方案.21d為1箇療程,治療3箇療程後,觀察近期療效、中醫臨床癥候變化、治療前後生活質量和免疫功能的變化以及化療不良反應.結果 治療組近期療效有效率為81.0%;中醫臨床癥候改善有效率為92.9%;生活質量KPS評分與對照組比較差異有統計學意義(P<0.05);治療組T細胞亞群水平變化與對照組比較差異有統計學意義(P<0.05);化療不良反應基本在可控製範圍內.結論 肺康飲結閤化療治療中晚期非小細胞肺癌,可顯著提高患者機體免疫功能,改善生活質量,是一種療效肯定、安全性高的綜閤治療方法.
목적 관찰폐강음결합화료개선중만기비소세포폐암환자생활질량급궤체면역공능적작용.방법 장84례중만기비소세포폐암환자수궤분위치료조화대조조,각42례.대조조단순GP화료방안,치료조채용중약복방폐강음구복액결합GP화료방안.21d위1개료정,치료3개료정후,관찰근기료효、중의림상증후변화、치료전후생활질량화면역공능적변화이급화료불량반응.결과 치료조근기료효유효솔위81.0%;중의림상증후개선유효솔위92.9%;생활질량KPS평분여대조조비교차이유통계학의의(P<0.05);치료조T세포아군수평변화여대조조비교차이유통계학의의(P<0.05);화료불량반응기본재가공제범위내.결론 폐강음결합화료치료중만기비소세포폐암,가현저제고환자궤체면역공능,개선생활질량,시일충료효긍정、안전성고적종합치료방법.
Objective To observe the improvement of the life quality and the immune function of the patients by using Fei Kang Yin combining with chemotherapy in the middle advanced non-small cell lung cancer.Methods 84 patients were randomly divided into treatment group and control group,42 cases in each group.The control group received GP regimen and treatment group received GP regimen combined with oral liquid of Fei Kang Yin.21 days were a course of treatment.The resent effect,traditional chinese medicine (TCM) clinical syndromes,the change of life quality and immune function after treatment and adverse reactions to chemotherapy were observed after three courses of treatment.Results The effective rate was 81.0% in the resent effect of the treatment group and the effective rate of improvement in TCM clinical syndromes was 92.9%.There was significant difference in quality of life in KPS between treatment group and control group (P <0.05).There was significant difference in the changes of T lymphocyte subset between treatment group and control group (P <0.05).Adverse reactions to chemotherapy were under control.Conclusions Fei Kang Yin chemotherapy can improve life quality in middle advanced non small cell lung cancer,and it is a safe and high security comprehensive therapy.